Document Detail

Dose-dependent effects of ladostigil on microglial activation and cognition in aged rats.
MedLine Citation:
PMID:  23325108     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Ladostigil (1 mg/kg/day) prevents the development of age-related memory deficits by a combination of immunomodulatory and antioxidant effects. A dose causing 30 % ChE inhibition is necessary in order to reverse existing memory deficits at 20 months of age.
Marta Weinstock; Corina Bejar; Donna Schorer-Apelbaum; Rony Panarsky; Lisandro Luques; Shai Shoham
Related Documents :
17597608 - Antithrombotic and hemostatic effects of a small molecule factor xia inhibitor in rats.
24995298 - Toxicity profile of a nutraceutical formulation derived from green mussel perna viridis.
12538808 - Antithrombotic properties of ssr182289a, a new, orally active thrombin inhibitor.
20731638 - The effect of low molecular weight heparin (enoxaparin) on enhanced coagulation induced...
1539168 - Induction of metallothionein by cadmium-metallothionein in rat liver: a proposed mechan...
9888628 - The development of addiction to d-amphetamine in an animal model: same principles as fo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2013-01-17
Journal Detail:
Title:  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology     Volume:  8     ISSN:  1557-1904     ISO Abbreviation:  J Neuroimmune Pharmacol     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-28     Completed Date:  2013-08-16     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  101256586     Medline TA:  J Neuroimmune Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  345-55     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aging / drug effects*,  pathology*
Antigens, CD11b / metabolism
Antigens, CD3 / metabolism
Brain / pathology
Cholinesterase Inhibitors / pharmacology*
Cholinesterases / metabolism
Cognition / drug effects*
Dose-Response Relationship, Drug
Enzyme-Linked Immunosorbent Assay
Indans / pharmacology*
Interferon-gamma / metabolism
Killer Cells, Natural / metabolism
Macrophage Activation / drug effects*
Maze Learning / drug effects
Memory, Long-Term / drug effects
Microglia / drug effects*
Monoamine Oxidase / metabolism
Rats, Wistar
Recognition (Psychology) / drug effects
Spleen / cytology,  drug effects
Th1 Cells / metabolism
Reg. No./Substance:
0/(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate; 0/Antigens, CD11b; 0/Antigens, CD3; 0/Cholinesterase Inhibitors; 0/Indans; 82115-62-6/Interferon-gamma; EC Oxidase; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Curcumin Ameliorates the Neurodegenerative Pathology in A53T ?-synuclein Cell Model of Parkinson's D...
Next Document:  Genome-wide maps of polyadenylation reveal dynamic mRNA 3'-end formation in mammalian cell lineages.